r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

JK

Jon Faiz Kayyem

Insider · Director · INBX

Jon Faiz Kayyem files insider transactions with the SEC as a director of Inhibrx (INBX). We hold 1 disclosed purchase or sale filed since 8 January 2008, 1 of them in the last 90 days.

  • Files forINBX
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure8 September 2026

Positions held

5 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 7 June 2021 — 8 September 2026Director · Inhibrx (INBX)44 Form 4 lines · source: SEC Form 4
  • Filed 6 December 2021 — 2 January 2026Director · Biodesix (BDSX)22 Form 4 lines · source: SEC Form 4
  • Filed 29 May 2024 — 30 May 2024Director · Inhibrx Biosciences (INXB)4 Form 4 lines · source: SEC Form 4
  • Filed 3 June 2010 — 2 February 2018SVP, Research & Development · GenMark Diagnostics (GNMK)92 Form 4 lines · source: SEC Form 4
  • Filed 4 January 2008 — 31 October 200810% owner · Repros Therapeutics (RPRX)7 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.